Phycin
Frederick, US · Maryland corporation · 2 known investors
Phycin develops engineered growth factors designed for higher stability and performance, including a thermostable recombinant basic fibroblast growth factor (bFGF) that remains active for 21+ days at 37°C. Its products target researchers and clinicians working in regenerative medicine, cell culture, and related life science applications.
Founders & leadership
WJ
Wang JunNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$200K disclosed across 1 of 2 rounds · 2024–2026
▶$200KraisedJul 2024 · 1 investors · OtherRule 506(b)
▶$200KraisedJul 2024 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Wang JunExecutive Officer, Director
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Jun 2024
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Phycin do?
- Phycin develops engineered growth factors designed for higher stability and performance, including a thermostable recombinant basic fibroblast growth factor (bFGF) that remains active for 21+ days at 37°C. Its products target researchers and clinicians working in regenerative medicine, cell culture, and related life science applications.
- Who are Phycin's investors?
- Phycin's investors include Maryland TEDCO, TEDCO.
- How much funding has Phycin raised?
- Phycin has disclosed $200K raised across 1 of its 2 known rounds.
- Where is Phycin headquartered?
- Phycin is headquartered in Frederick, US.